{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:59:13Z","timestamp":1792205953037,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.imbio.2011.11.010","type":"journal-article","created":{"date-parts":[[2011,12,8]],"date-time":"2011-12-08T23:21:34Z","timestamp":1323386494000},"page":"704-710","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Impact of valproic acid on dendritic cells function"],"prefix":"10.1016","volume":"217","author":[{"given":"Jihane","family":"Frikeche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eolia","family":"Brissot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Gr\u00e9goire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Gaugler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Mohty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2011.11.010_bib0005","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.canlet.2009.02.019","article-title":"Development of the pan-DAC inhibitor panobinostat (LBH589): successes and challenges","volume":"280","author":"Atadja","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.imbio.2011.11.010_bib0010","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1365-2567.2007.02678.x","article-title":"Histone deacetylase inhibitors decrease Toll-like receptor-mediated activation of proinflammatory gene expression by impairing transcription factor recruitment","volume":"122","author":"Bode","year":"2007","journal-title":"Immunology"},{"key":"10.1016\/j.imbio.2011.11.010_bib0015","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1182\/blood-2006-04-019711","article-title":"Histone deacetylase activities are required for innate immune cell control of Th1 but not Th2 effector cell function","volume":"109","author":"Brogdon","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2011.11.010_bib0020","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1002\/cncr.21589","article-title":"Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemia","volume":"104","author":"Bug","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.imbio.2011.11.010_bib0025","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jneuroim.2005.02.022","article-title":"Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis","volume":"164","author":"Camelo","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.imbio.2011.11.010_bib0030","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1182\/blood-2003-01-0233","article-title":"NVP-LAQ824 is a potent novel histone deacetylase inhibitor with significant activity against multiple myeloma","volume":"102","author":"Catley","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2011.11.010_bib0035","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2119\/molmed.2011.00007","article-title":"HDAC inhibition and graft versus host disease","volume":"17","author":"Choi","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.imbio.2011.11.010_bib0040","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2222.2004.02006.x","article-title":"Trichostatin A attenuates airway inflammation in mouse asthma model","volume":"35","author":"Choi","year":"2005","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.imbio.2011.11.010_bib0045","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.pharmtox.45.120403.095825","article-title":"Clinical development of histone deacetylase inhibitors as anticancer agents","volume":"45","author":"Drummond","year":"2005","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.imbio.2011.11.010_bib0050","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ctrv.2007.11.003","article-title":"Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors","volume":"34","author":"Duenas-Gonzalez","year":"2008","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.imbio.2011.11.010_bib0055","doi-asserted-by":"crossref","first-page":"426","DOI":"10.2119\/molmed.2011.00069","article-title":"Inhibition of histone deacetylases in inflammatory bowel diseases","volume":"17","author":"Glauben","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.imbio.2011.11.010_bib0060","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nri2225","article-title":"How microorganisms tip the balance between interleukin-12 family members","volume":"8","author":"Goriely","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imbio.2011.11.010_bib0065","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1182\/blood.V90.5.1920","article-title":"Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype","volume":"90","author":"Hilkens","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2011.11.010_bib0070","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00277-005-1104-7","article-title":"Treatment with valproic acid for myelofibrosis with myeloid metaplasia","volume":"84","author":"Inoue","year":"2005","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.imbio.2011.11.010_bib0075","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1182\/blood-2003-12-4333","article-title":"Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid","volume":"104","author":"Kuendgen","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2011.11.010_bib0080","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1073\/pnas.052702999","article-title":"The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines","volume":"99","author":"Leoni","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.imbio.2011.11.010_bib0085","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1600-065X.2008.00700.x","article-title":"Regulation of interleukin-12\/interleukin-23 production and the T-helper 17 response in humans","volume":"226","author":"Lyakh","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.imbio.2011.11.010_bib0090","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/35106079","article-title":"Histone deacetylases and cancer: causes and therapies","volume":"1","author":"Marks","year":"2001","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.imbio.2011.11.010_bib0095","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.it.2005.10.003","article-title":"Understanding the IL-23-IL-17 immune pathway","volume":"27","author":"McKenzie","year":"2006","journal-title":"Trends Immunol."},{"key":"10.1016\/j.imbio.2011.11.010_bib0100","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc1779","article-title":"Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer","volume":"6","author":"Minucci","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.imbio.2011.11.010_bib0105","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/ni0703-603","article-title":"Chromatin dynamics and locus accessibility in the immune system","volume":"4","author":"Mostoslavsky","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imbio.2011.11.010_bib0110","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/ni1223","article-title":"Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells","volume":"6","author":"Napolitani","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imbio.2011.11.010_bib0115","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1158\/1078-0432.CCR-06-2903","article-title":"Histone deacetylase inhibitors affect dendritic cell differentiation and immunogenicity","volume":"13","author":"Nencioni","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.imbio.2011.11.010_bib0120","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/CJI.0b013e31818403bc","article-title":"Dendritic cells: a critical player in cancer therapy?","volume":"31","author":"Palucka","year":"2008","journal-title":"J. Immunother."},{"key":"10.1016\/j.imbio.2011.11.010_bib0125","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.bcp.2005.04.030","article-title":"HDAC inhibition prevents NF-kappa B activation by suppressing proteasome activity: down-regulation of proteasome subunit expression stabilizes I kappa B alpha","volume":"70","author":"Place","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.imbio.2011.11.010_bib0130","first-page":"2562","article-title":"Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice","volume":"118","author":"Reddy","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imbio.2011.11.010_bib0135","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1084\/jem.179.4.1109","article-title":"Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte\/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha","volume":"179","author":"Sallusto","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2011.11.010_bib0140","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/leu.2010.244","article-title":"HDAC inhibition by LBH589 affects the phenotype and function of human myeloid dendritic cells","volume":"25","author":"Song","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.imbio.2011.11.010_bib0145","doi-asserted-by":"crossref","first-page":"5899","DOI":"10.4049\/jimmunol.0804388","article-title":"Cutting edge: negative regulation of dendritic cells through acetylation of the nonhistone protein STAT-3","volume":"182","author":"Sun","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2011.11.010_bib0150","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1073\/pnas.93.6.2588","article-title":"CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells","volume":"93","author":"Zhou","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298511002609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298511002609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:32:30Z","timestamp":1759249950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298511002609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0171298511002609"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2011.11.010","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of valproic acid on dendritic cells function","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2011.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}